2. Academic Validation
  3. Discovery of novel structural imidazolylvinylquinolones exerting excellent broad-spectrum antibacterial efficacy with multitargeting potential

Discovery of novel structural imidazolylvinylquinolones exerting excellent broad-spectrum antibacterial efficacy with multitargeting potential

  • Eur J Med Chem. 2026 Apr 5:307:118643. doi: 10.1016/j.ejmech.2026.118643.
Yi-Min Tan 1,  Aisha Bibi 1,  Jin-Ping Chen 1,  Wei-Wei Gao 2,  Yu Cheng 3,  Cheng-He Zhou 4
Affiliations

Affiliations

  • 1 Institute of Bioorganic & Medicinal Chemistry, Key Laboratory of Applied Chemistry of Chongqing Municipality, School of Chemistry and Chemical Engineering, Southwest University, Chongqing, 400715, China.
  • 2 State Key Laboratory Base of Eco-chemical Engineering, College of Chemical Engineering, Qingdao University of Science and Technology, Qingdao, 266042, China. Electronic address: gww501@qust.edu.cn.
  • 3 Ministry of Education Key Laboratory of Molecular and Cellular Biology, Hebei Anti-Tumor Molecular Target Technology Innovation Center, Hebei Research Center of the Basic Discipline of Cell Biology, College of Life Science, Hebei Normal University, Shijiazhuang, 050024, China. Electronic address: chengyu@hebtu.edu.cn.
  • 4 Institute of Bioorganic & Medicinal Chemistry, Key Laboratory of Applied Chemistry of Chongqing Municipality, School of Chemistry and Chemical Engineering, Southwest University, Chongqing, 400715, China. Electronic address: zhouch@swu.edu.cn.
PMID: 41653776 DOI: 10.1016/j.ejmech.2026.118643
Abstract

A unique type of imidazolylvinylquinolones (IVQs) as novel structural scaffold were developed which afforded excellent broad-spectrum Antibacterial efficacy with multitargeting potential. Most of the prepared IVQs gave high Antibacterial activity and broad Antibacterial spectrum, and especially ethyl IVQ 14a, in which the ethyl group was the most suitable fragment among all the investigated substituents to perform the most effective biosupramolecular effect, showed potent Antibacterial activity against MRSA (MIC = 0.25 μg/mL), with an enhanced efficacy 16-fold that of ciprofloxacin. Molecule 14a also demonstrated low drug resistance, hemolysis, and cytotoxicity, and rapidly bactericidal ability. Mechanism evaluation revealed that molecule 14a could not only interfere with membranous function and form DNA-14a supramolecular complex by intercalation that might obstruct DNA replication, but also effectively interact with Lactate Dehydrogenase via hydrogen bonds which could obstruct the function of enzyme and inhibit Bacterial metabolism, thereby exerting potent bactericidal effect. These potential multitargeting Antibacterial actions enabled ethyl IVQ 14a to exhibit stronger anti-MRSA efficacy without the obvious development of Bacterial resistance than ciprofloxacin in vivo. This series of medicinal chemobiological evaluation towards the topic compounds strongly suggested the development potential of unique imidazolylvinylquinolones as novel structural scaffold to combat Bacterial resistance.

Keywords

Antibacterial; DNA; Imidazole; Multitargeting; Resistance.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z